NHS BLOOD & TRANSPLANT has a total of 52 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are BLOOD SYSTEMS INC, SUZHOU GENEPHARMA CO LTD and ASURAGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 15 | |
#2 | WIPO (World Intellectual Property Organization) | 12 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | United States | 6 | |
#5 | Canada | 4 | |
#6 | Israel | 4 | |
#7 | Australia | 3 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Chemical engineering | |
#5 | Measurement | |
#6 | Medical technology | |
#7 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Separation | |
#7 | Enzymes | |
#8 | Analysing materials | |
#9 | Object sterilising | |
#10 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Navarrete Cristina | 8 |
#2 | Podmore Adrian | 7 |
#3 | Dalton Joan | 6 |
#4 | Kumpalume Peter | 5 |
#5 | Girdlestone John | 5 |
#6 | Feldman Peter | 5 |
#7 | Harvey John | 4 |
#8 | Watt Suzanne | 4 |
#9 | Anstee David | 4 |
#10 | Lemnrau Alina | 3 |
Publication | Filing date | Title |
---|---|---|
GB202001795D0 | Method | |
GB201818045D0 | Method for producing erythroid cells | |
GB201304038D0 | Treated cells and therapeutic uses | |
WO2013128199A1 | A method of molecular typing | |
GB201219226D0 | Method for detecting cation leaks | |
GB201211571D0 | A method of molecular typing | |
GB201207831D0 | A method for selecting donors and recipients for transplantation | |
GB201203485D0 | A method of molecular typing | |
GB201200458D0 | Methods of preparing cells and compositions | |
GB201121101D0 | A method of preparing isolated cells and uses | |
GB201118024D0 | Therapeutic compositions and uses | |
GB201115460D0 | Method of detecting microbial contamination | |
GB201015606D0 | Modulation of stem cell homing and engraftment | |
GB201007159D0 | Method for evaluating anglogenic potential | |
US2008293623A1 | Enriched haptoglobin polymers for the treatment of disease | |
GB0710321D0 | Method | |
GB0524432D0 | Method |